299 related articles for article (PubMed ID: 12640381)
1. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome.
Veyradier A; Obert B; Haddad E; Cloarec S; Nivet H; Foulard M; Lesure F; Delattre P; Lakhdari M; Meyer D; Girma JP; Loirat C
J Pediatr; 2003 Mar; 142(3):310-7. PubMed ID: 12640381
[TBL] [Abstract][Full Text] [Related]
2. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome.
Hunt BJ; Lämmle B; Nevard CH; Haycock GB; Furlan M
Thromb Haemost; 2001 Jun; 85(6):975-8. PubMed ID: 11434704
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Remuzzi G; Galbusera M; Noris M; Canciani MT; Daina E; Bresin E; Contaretti S; Caprioli J; Gamba S; Ruggenenti P; Perico N; Mannucci PM;
Blood; 2002 Aug; 100(3):778-85. PubMed ID: 12130486
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
[TBL] [Abstract][Full Text] [Related]
6. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
7. [Atypical hemolytic and uremic syndrome associated with von Willebrand factor-cleaving protease (ADAMTS 13) deficiency in children].
Ben Abdallah Chabchoub R; Boukedi A; Bensalah M; Maalej B; Gargour L; Turk F; Ben Halima N; Wolf M; Veyradier A; Mahfoudh A
Arch Pediatr; 2013 Aug; 20(8):853-7. PubMed ID: 23827373
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
Kremer Hovinga JA; Studt JD; Alberio L; Lämmle B
Semin Hematol; 2004 Jan; 41(1):75-82. PubMed ID: 14727262
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome.
Tsai HM; Chandler WL; Sarode R; Hoffman R; Jelacic S; Habeeb RL; Watkins SL; Wong CS; Williams GD; Tarr PI
Pediatr Res; 2001 May; 49(5):653-9. PubMed ID: 11328948
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.
Fujimura Y; Matsumoto M; Yagi H; Yoshioka A; Matsui T; Titani K
Int J Hematol; 2002 Jan; 75(1):25-34. PubMed ID: 11843286
[TBL] [Abstract][Full Text] [Related]
12. Platelets: thrombotic thrombocytopenic purpura.
George JN; Sadler JE; Lämmle B
Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
[TBL] [Abstract][Full Text] [Related]
13. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
14. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.
Veyradier A; Obert B; Houllier A; Meyer D; Girma JP
Blood; 2001 Sep; 98(6):1765-72. PubMed ID: 11535510
[TBL] [Abstract][Full Text] [Related]
15. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165
[TBL] [Abstract][Full Text] [Related]
16. [TTP/HUS and VWF/ADAMTS-13].
Fujimura Y
Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
[No Abstract] [Full Text] [Related]
17. [Pathophysiology of thrombotic microangiopathies: current understanding].
Coppo P; Veyradier A; Durey MA; Fremeaux-Bacchi V; Scrobohaci ML; Amesland F; Bussel A
Ann Med Interne (Paris); 2002 May; 153(3):153-66. PubMed ID: 12218898
[TBL] [Abstract][Full Text] [Related]
18. [Progress on TTP/HUS diagnosis with analysis of VWF-cleaving protease activation].
Fujimura Y
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):451-9. PubMed ID: 15052802
[No Abstract] [Full Text] [Related]
19. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
20. Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiency.
te Loo DM; Levtchenko E; Furlan M; Roosendaal GP; van den Heuvel LP
Pediatr Nephrol; 2000 Aug; 14(8-9):762-5. PubMed ID: 10955922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
